GENOMIC VALLEY BIOTECH

BSE: 539206 09 Sep 2025

Healthcare

₹ 41.56

GENOMIC VALLEY BIOTECH LIMITED specializes in Biotechnology within the Healthcare sector.

GENOMIC VALLEY BIOTECH

BSE: 539206 09 Sep 2025

Healthcare

₹ 41.56

GENOMIC VALLEY BIOTECH LIMITED specializes in Biotechnology within the Healthcare sector.

Book Value

12.7

Dividend Yield

0.0%

Debt to Equity

0.0

Stock P/E

50.0

Market Cap

12.5 Cr

GENOMIC VALLEY BIOTECH - Share Price & Details

Market Cap

₹12.5

High /Low

108.0 / 37.1

Stock P/E

50.0

Book Value

₹12.7

Dividend Yield

0.0

ROCE

11.8

ROE

₹9.68

Face Value

10.0

PEG Ratio

1.19

EVEBITDA

₹36.6

Debt

0.00

CMP / FCF

54.4

Debt to equity

₹0.0

NP Ann

0.36

High price all time

108.0

Piotroski score

₹7.0

Graham Number

15.3

No. Eq. Shares

0.31

Net CF

₹0.04

Net profit

0.25

Price to book value

3.21

Interest Coverage

₹NA

Low price all time

8.25

Industry PE

64.9

Reserves

₹0.84

Free Cash Flow

₹0.02

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.46	91.0
Triochem Products Ltd.,	NA	NA	NA	NA	0
GENOMIC VALLEY BIOTECH LIMITED	NA	NA	NA	NA	12.5	50.0
DECIPHER LABS LIMITED	NA	NA	NA	NA	11.4
DR LALCHANDANI LABS LIMITED	NA	NA	NA	NA	11.3	26.8

Peer Comparison Chart

About GENOMIC VALLEY BIOTECH

GENOMIC VALLEY BIOTECH LIMITED, with Security Code 539206, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Genomic Valley Standalone June 2025 Net Sales at Rs 0.09 crore, down 42.05% Y-o-Y

(19 Aug 2025)

Quarterly Net Profit at Rs. 0.02 crore in June 2025 down 80.68% from Rs. 0.13 crore in June 2024. EBITDA stands at Rs. 0.02 crore in June...

Talbros Automotive Components consolidated net profit rises 7.71% in the June 2025 quarter

(09 Aug 2025)

Net profit of Talbros Automotive Components rose 7.71% to Rs 22.20 crore in the quarter ended June 2025 as against Rs 20.61 crore during the...

Panafic Industrials standalone net profit rises 50.00% in the June 2025 quarter

(09 Aug 2025)

Net profit of Panafic Industrials rose 50.00% to Rs 0.06 crore in the quarter ended June 2025 as against Rs 0.04 crore during the previous...

Genomic Valley Biotech standalone net profit declines 84.62% in the June 2025 quarter

(08 Aug 2025)

Net profit of Genomic Valley Biotech declined 84.62% to Rs 0.02 crore in the quarter ended June 2025 as against Rs 0.13 crore during the previous quarter...

Where Could Genomic Valley Biotech Limited (539206) Be Headed - Get exclusive market insights for better trading

(06 Aug 2025)

Where Could Genomic Valley Biotech Limited (539206) Be Headed ✌️【Market Discussions】✌️ Stay informed about every major movement in the...

What are the technical indicators suggesting about WLFC - Get expert advice on portfolio optimization

(06 Aug 2025)

【Stock Highlights】✌️ Get real-time alerts, full technical breakdowns, and forward-looking strategies that position you for market-beating...

Quarterly Table

Standalone

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	0.7	1.0	0.1	0.1	0.0	0.0	0.2	0.2	0.2	0.3
Expenses	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2
Operating Profit	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1
OPM %	5.06%	95.08%	44.07%	35.29%	56.41%	0%	81.94%	68.78%	70.91%	24.62%
Other Income	-0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1
Tax %	0%	-0.1%	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	-0.9	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	-0.1
EPS in Rs	-2.79	3.21	0.09	0.08	0.07	-0.15	0.42	0.48	0.51	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	7%
5 Years:	-30%
3 Years:	-7%
TTM:	-50%

Compounded Profit Growth
10 Years:	0%
5 Years:	-39%
3 Years:	27%
TTM:	-61%

Stock Price CAGR
10 Years:	0%
5 Years:	39%
3 Years:	17%
1 Year:	42%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	0%
1 Year:	0%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

GENOMIC VALLEY BIOTECH

GENOMIC VALLEY BIOTECH

GENOMIC VALLEY BIOTECH - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About GENOMIC VALLEY BIOTECH

Latest News

Genomic Valley Standalone June 2025 Net Sales at Rs 0.09 crore, down 42.05% Y-o-Y

Talbros Automotive Components consolidated net profit rises 7.71% in the June 2025 quarter

Panafic Industrials standalone net profit rises 50.00% in the June 2025 quarter

Genomic Valley Biotech standalone net profit declines 84.62% in the June 2025 quarter

Where Could Genomic Valley Biotech Limited (539206) Be Headed - Get exclusive market insights for better trading

What are the technical indicators suggesting about WLFC - Get expert advice on portfolio optimization

Does Resideo Technologies Inc. stock perform well during market downturns - Build wealth steadily with proven stock picks

When is Terex Corporation stock expected to show significant growth - Maximize your portfolio’s earning potential

Genomic Valley Biotech Limited (539206)’s Trend in 2025 - Superior investment outcomes

Genomic Valley Biotech Limited (539206) to Launch New Product Line - Dynamic investment growth

Technical Analysis: Genomic Valley Biotech Limited (539206) - Breakthrough profit margins

Genomic Valley Biotech Limited (539206)’s Trend in 2025 - Dynamic investment growth

Genomic Valley Biotech Limited (539206)’s Trend in 2025 - Market-leading growth rates

Bullish Pattern Emerging on Genomic Valley Biotech Limited (539206) - Breakthrough capital growth

Genomic Valley Biotech Limited (539206)’s Trend in 2025 - Consistently high returns

Genomic Valley Biotech Limited (539206) Expands into New Market - Dynamic growth stocks

Genomic Valley Biotech Limited (539206)’s Trend in 2025 - Rapidly growing investment returns

Best Investment Stocks for 2025 Premium Investor Signals - Double or triple returns

Kimia Biosciences Limited (530313) Gets Regulatory Approval - Record-setting profit potential

Genomic Valley Biotech Limited (539206)’s Trend in 2025 - Consistent high-performance stocks

GSK licenses Shigella vaccine candidate to Bharat Biotech for continued development

Bharat Biotech launches India’s only vertically integrated cell and gene therapy, viral production facility at Genome Valley

Miltenyi Biotec inaugurates India’s first cell and gene therapy CoE in Hyderabad

Q3 Results: RVNL, EaseMyTrip, MTNL, Aditya Birla Fashion And Others To Announce Earnings Today; Full List Here

Why a silly-sounding name suits the serious mission of our biotech spin-off

Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

Telangana secures over Rs 36,000 crore in life sciences investments, genome valley leads the way

Telangana attracts Rs 36000 crore investments in life sciences in 1 year creating 51000 direct jobs

Genomic Valley Standalone September 2024 Net Sales at Rs 0.21 crore, up 203.61% Y-o-Y

Genomic Valley Biotech standalone net profit rises 650.00% i

Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter

RateGain announces extended collaboration with FlyArystan

Lemon Tree Hotels signs a new property in Udaipur

Q2 earnings season begins: TCS, IREDA, Tata Elxsi, DMart to release Q2FY25 results this week; Here is the full list

20 Top Biotech Companies in India

Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2024

Top news today: NCLAT to hear Byju’s appeal against insolvency; 85 mainboard companies to declare Q1 results, and more | Today News

Q1 Results This Week: Adani Power, Zomato, SBI, Tata Motors Among 250+ Firms To Declare Earnings

Q1 Results This Week: Zomato, ITC, Tata Motors, SBI Among 250+ Firms To Declare Earnings

Q1 Results This Week: Delhivery, Infibeam Avenues, Aeroflex Industries Among 130+ Firms To Declare Earnings

Genomic Valley Standalone June 2024 Net Sales at Rs 0.16 crore, up 165.24% Y-o-Y

Genomic Valley Biotech standalone net profit rises 333.33% in the June 2024 quarter

94 Companies, Along With Adani Group Giants, Bharat Electronics & Hindustan Petroleum To Declare Q1 Results Today

Q1 Results Today: Adani Total Gas, HPCL, Pfizer Among 90+ Firms To Declare Earnings

94 Companies, Along With Adani Group Giants, Bharat Electronics & Hindustan Petroleum To Declare Q1 Results

Q1 results today: HPCL, Bharat Electronics, ACC, Adani Total Gas, others to post earnings on July 29; check list

94 Major Companies Including ACC, Pfizer, and Adani Report Q1 Earnings Today

Q1 results today: 94 companies including ACC, Pfizer, Adani Total Gas, Adani Wilmar to report earnings on July 29 | Company Business News

Top news today: NCLAT to hear Byju’s appeal against insolvency; 85 mainboard companies to declare Q1 results, and more

Q1 results today: 94 companies including ACC, Pfizer, Adani Total Gas, Adani Wilmar to report earnings on July 29

Q1 results: SBI, Tata Steel, Coal India, BHEL, Pfizer, and Sun Pharma among companies to declare earnings next week | Stock Market News

Q1 results: SBI, Tata Steel, Coal India, BHEL, Pfizer, and Sun Pharma among companies to declare earnings next week

Ajooni Biotech standalone net profit rises 68.52% in the March 2024 quarter

Genomic Valley Biotech Dt Share Price Today - Genomic Valley Biotech Dt Stock Price Live NSE/BSE

Q4 results today: SBI, HPCL, BPCL, others to post earnings on May 9; check list

How Telangana is Targeting Innovation Beyond Generics

Tata Sons may fetch up to ₹8 trillion valuation in IPO, says Spark PWM | Stock Market News

Bottomline | Beware the small-cap frenzy!

Buy or sell: Vaishali Parekh recommends three stocks to buy today — March 1 | Stock Market News

‘10,000 genome’ project completed, says government

22 Biotech Companies in Hyderabad to Know

Shares below Rs 100: Only buyers were seen in these stocks on December 21

Patanjali Foods, Thomas Cook, and MMTC shares rise after price band revision

BSV to set up manufacturing facility at Hyderabad’s Genome Valley

Fractal Genome: Post Genome Era Analytics To Rescue India’s Opportunities in IT-led Pharma Biotech

Genomic Valley Biotech Limited Appoints Yogesh Agrawal as Chief Financial Officer

10,000 Indian genomes to be sequenced by year-end

Genomics Theme Of Shenandoah Valley Biotechnology Symposium

Genome Valley: Home to Asia’s largest life sciences cluster

Gland Pharma to expand in Genome Valley with ₹400 crore investment

Genome Valley Excellence Award for Moderna co-founder Robert S. Langer